Cargando…

Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial

OBJECTIVE: The objective was to compare the safety and cellular immunogenicity of intradermal versus intramuscular immunization with an HIV-lipopeptide candidate vaccine (LIPO-4) in healthy volunteers. METHODOLOGY: A randomized, open-label trial with 24 weeks of follow-up was conducted in France at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Launay, Odile, Durier, Christine, Desaint, Corinne, Silbermann, Benjamin, Jackson, Angela, Pialoux, Gilles, Bonnet, Bénédicte, Poizot-Martin, Isabelle, Gonzalez-Canali, Gustavo, Cuzin, Lise, Figuereido, Suzanne, Surenaud, Mathieu, Hamouda, Nadine Ben, Gahery, Hanne, Choppin, Jeannine, Salmon, Dominique, Guérin, Corinne, Villada, Isabelle Bourgault, Guillet, Jean-Gérard
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1942115/ https://www.ncbi.nlm.nih.gov/pubmed/17712402 http://dx.doi.org/10.1371/journal.pone.0000725

Ejemplares similares

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
por: Salmon-Céron, D, et al.
Publicado: (2009)

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4
por: Grabar, Sophie, et al.
Publicado: (2017)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
por: Shili-Masmoudi, Sarah, et al.
Publicado: (2019)

HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 “Aging” Study
por: Perrin, Sophie, et al.
Publicado: (2012)

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
por: Salmon-Ceron, Dominique, et al.
Publicado: (2012)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC)
por: Protière, Christel, et al.
Publicado: (2017)

HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study
por: Perrin, Sophie, et al.
Publicado: (2012)

Correction: HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study
por: Perrin, Sophie, et al.
Publicado: (2013)

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
por: Villefroy, Pascale, et al.
Publicado: (2006)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
por: Loko, Marc-Arthur, et al.
Publicado: (2010)

Machine Learning to Improve the Effectiveness of ANRS in Predicting HIV Drug Resistance
por: Singh, Yashik
Publicado: (2017)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment
por: Protiere, Christel, et al.
Publicado: (2020)

NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Educational intervention and HIV infection: preliminary results
por: Bregigeon, Sylvie, et al.
Publicado: (2010)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017
por: Castry, Mathieu, et al.
Publicado: (2021)

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study
por: Breton, Guillaume, et al.
Publicado: (2022)

Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)
por: Chawki, Sylvain, et al.
Publicado: (2021)

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
por: Billa, Oumar, et al.
Publicado: (2018)

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)
por: Yaya, Issifou, et al.
Publicado: (2018)

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
por: Loret, Erwann P., et al.
Publicado: (2016)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
por: Loret, Erwann P., et al.
Publicado: (2016)

Associations between 25-Hydroxyvitamin D and Immunologic, Metabolic, Inflammatory Markers in Treatment-Naive HIV-Infected Persons: The ANRS CO9 «COPANA» Cohort Study
por: Legeai, Camille, et al.
Publicado: (2013)

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study
por: Cuzin, Lise, et al.
Publicado: (2017)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
por: Antwerpes, Saskia, et al.
Publicado: (2020)

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
por: Lévy, Yves, et al.
Publicado: (2020)

Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon
por: Sidze, Larissa Kamgue, et al.
Publicado: (2015)

Impact of maraviroc on immune restoration in an advanced stage HIV-infected patient
por: Bregigeon, Sylvie, et al.
Publicado: (2010)

Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
por: Dalmasso, Cyril, et al.
Publicado: (2008)

Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM)
por: Fiorentino, Marion, et al.
Publicado: (2021)

Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation
por: Balducci, Estelle, et al.
Publicado: (2019)

Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial
por: Auvert, Bertran, et al.
Publicado: (2005)

Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon
por: Tejiokem, Mathurin C., et al.
Publicado: (2011)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
por: Plaçais, Léo, et al.
Publicado: (2021)

Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhu3oo6t2hmh858pog5eaqb4t5